Award recordCONTRACT

ABBOTT MOLECULAR INC.

PIID 36C10X21N0048· VA Staff Offices· SAC FREDERICK (36C10X)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2021· $1,135,789 net obligations· UEI NK5QDVJBHMN7· IL

Description

ABBOTT M2000 COVID-19 REAGENTS FOR USE IN ABBOTT M2000 REALTIME SYSTEMS - DEOBLIGATE FUNDS

Base award description: ABBOTT M2000 COVID-19 REAGENTS FOR USE IN ABBOTT M2000 REALTIME SYSTEMS

First action · last action
2021-03-16 · 2022-08-25
Transactions
3
First transaction's obligation
$14,563,079
Base + all options value (sum of deltas)
$1,135,789
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C10X21D0013
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$14,563,079$0Base award · 2021-03-16 · this action $14,563,079 · running total $14,563,079Modification P00001 · 2021-09-29 · this action $0 · running total $14,563,079Modification P00002 · 2022-08-25 · this action -$13,427,290 · running total $1,135,789
  • Base2021-03-16+$14,563,079= $14,563,079
  • Mod P000012021-09-29+$0= $14,563,079
  • Mod P000022022-08-25-$13,427,290= $1,135,789
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-03-16+$14,563,079$14,563,079ABBOTT M2000 COVID-19 REAGENTS FOR USE IN ABBOTT M2000 REALTIME SYSTEMS
Mod P00001· OTHER ADMINISTRATIVE ACTION2021-09-29+$0$14,563,079ABBOTT M2000 COVID-19 REAGENTS FOR USE IN ABBOTT M2000 REALTIME SYSTEMS
Mod P00002· FUNDING ONLY ACTION2022-08-25−$13,427,290$1,135,789ABBOTT M2000 COVID-19 REAGENTS FOR USE IN ABBOTT M2000 REALTIME SYSTEMS - DEOBLIGATE FUNDS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NK5QDVJBHMN7)

AwardOffice · PSC / listingNet obligationsFY
36C24126N0799241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$658,750FY2026
36C26326P0588NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$308,299FY2026
36C24126A0041241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$0FY2026
36C24226N0439242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$1,481,077FY2026
36C24926N0423249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$471,122FY2026
36C24626N0476246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$421,178FY2026

Other recipients under 6550 from SAC FREDERICK (36C10X) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C10X22C0007BECTON, DICKINSON AND COMPANYSAC FREDERICK (36C10X)$74,942,246FY2022
36C10X21N0105CEPHEIDSAC FREDERICK (36C10X)$27,353,200FY2021
36C10X21N0103CEPHEIDSAC FREDERICK (36C10X)$148,585FY2021
36C10X21N0086CEPHEIDSAC FREDERICK (36C10X)$594,340FY2021
36C10X21N0066CEPHEIDSAC FREDERICK (36C10X)$297,170FY2021

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C10X21N0048_3600_36C10X21D0013_3600 · retrieved 2026-09-26.